beta-D-Galp-(1->4)-alpha-D-Galp-(1->4)-beta-D-Glcp

Term ID

CHEBI:148331

Synonyms

(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-galacto-hexopyranosyl-(1->4)-alpha-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranose
beta-D-galactopyranosyl-(1->4)-alpha-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
Gal(b1-4)Gal(a1-4)b-Glc

Definition

A trisaccharide consisting of β-D-galactopyranose, α-D-galactopyranose and β-D-glucopyranose residues joined in sequence by (1→4) glycosidic bonds.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-alpha-D-Galp-(1->4)-beta-D-Glcp

Phenotype where environments contain beta-D-Galp-(1->4)-alpha-D-Galp-(1->4)-beta-D-Glcp

Phenotype modified by environments containing beta-D-Galp-(1->4)-alpha-D-Galp-(1->4)-beta-D-Glcp

Phenotype affecting beta-D-Galp-(1->4)-alpha-D-Galp-(1->4)-beta-D-Glcp

Human Disease Model